Article
A simplified pyrazinamidase test for Mycobacterium tuberculosis pyrazinamide antimicrobial susceptibility testing.
Journal of clinical microbiology - 11 Dec 2024
Chan Hsin-Hua, Wang Yu-Chen, Jou Ruwen
Abstract excerpt
Pyrazinamide (PZA) is an important first-line drug for tuberculosis (TB) treatment by eradicating the persisting Mycobacterium tuberculosis complex (MTBC). Due to cost and technical challenges, end TB strategies are hampered by the lack of a simple and reliable culture-based PZA antimicrobial susceptibility testing (AST) for routine use. We initially developed a simplified chromogenic pyrazinamidase (PZase) test...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
